CSI Market
Sign In | Register

Sana Biotechnology Inc (SANA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SANA Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Sana Biotechnology Inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-110.85
Depreciation & amortization4.63
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability27.11
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Adjustments For Decrease IncreaseIn Other Assets0.00
Share-based Compensation11.00
Income (Loss) from Equity Method Investments0.00
Adjustments For Unrealised Foreign Exchange Losses Gains0.00
Change In Fair Value Of Success Payment Liabilities-2.31
Non Cash Expense In Connection With License Agreement-
Increase Decrease In Operating Lease Right Of Use Assets And Liabilities-1.50
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.40
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-5.97
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.92
Other Working Capital0.00
Other Noncash Income (Expense)4.87
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.36
Discontinued operations0.00
Net Cash flow from Operating Activities-70.17
Investing Activities
Capital Expenditures-1.91
Sale of Capital Items0.27
Proceeds from Sale and Maturity of Marketable Securities70.82
Payments to Acquire Marketable Securities-107.26
Payments for Tenant Improvements0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-38.08
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock89.95
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net3.50
Proceeds From Employee Stock Purchase Plan And Exercise Of Stock Options Net-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents76.07
Proceeds From Issuance Of Common Stock From Equity Financings Net-
Proceeds Fees Related To Common Stock Financings Net-
Principal Payments For Tenant Improvement Loan-
Proceeds Principal Payments Net For Tenant Improvement Loan-
Principal Payments Net For Tenant Improvement Loan-0.09
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities93.45
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-71.81
Total Cash Flow-14.80
4 historic quarters locked

Sign in to unlock the full Sana Biotechnology Inc cash flow history.

Sign In Create Free Account

About Sana Biotechnology Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-342395

Figures are derived from filed reports and may be restated. Historical data is subject to revision.